Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | BRD-K66453893 | CTRPv2 | pan-cancer | AAC | 0.068 | 0.04 |
mRNA | MLN2238 | CTRPv2 | pan-cancer | AAC | 0.075 | 0.04 |
mRNA | Bortezomib | CTRPv2 | pan-cancer | AAC | 0.075 | 0.04 |
mRNA | AZD8055 | CTRPv2 | pan-cancer | AAC | 0.077 | 0.04 |
mRNA | BRD-K09344309 | CTRPv2 | pan-cancer | AAC | 0.16 | 0.04 |
mRNA | BMS-345541 | GDSC1000 | pan-cancer | AAC | 0.068 | 0.04 |
mRNA | LY-2183240 | CTRPv2 | pan-cancer | AAC | 0.066 | 0.04 |
mRNA | BRD-K80183349 | CTRPv2 | pan-cancer | AAC | 0.068 | 0.05 |
mRNA | L-685458 | CCLE | pan-cancer | AAC | -0.094 | 0.05 |
mRNA | FK866 | GDSC1000 | pan-cancer | AAC | 0.067 | 0.05 |